UFF
GILD icon

USA Financial Formulas’s Gilead Sciences GILD Stock Holding History

USA Financial Formulas’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Sell
398
-9,406
-96% -$1.24M 0.01% 278
2026
Q1 		$1.37M Buy
9,804
+759
+8% +$106K 0.26% 23
2025
Q4 		$1.11M Buy
9,045
+8,985
+14,975% +$1.09M 0.2% 29
2025
Q3 		$6.66K Sell
60
-30,116
-100% -$3.42M ﹤0.01% 255
2025
Q2 		$3.35M Buy
30,176
+5,858
+24% +$623K 0.57% 19
2025
Q1 		$2.72M Buy
24,318
+7,654
+46% +$790K 0.45% 12
2024
Q4 		$1.54M Buy
+16,664
New +$1.5M 0.24% 16
2023
Q4 		– Sell
-27,283
Closed -$2.04M – 422
2023
Q3 		$2.04M Hold
27,283
– – 3.06% 6
2023
Q2 		$2.1M Sell
27,283
-13,836
-34% -$1.1M 3.23% 6
2023
Q1 		$3.41M Buy
+41,119
New +$3.41M 5.53% 2
2022
Q3 		$1K Sell
14
-25
-64% -$1.58K ﹤0.01% 235
2022
Q2 		$2K Buy
39
+25
+179% +$1.55K ﹤0.01% 201
2022
Q1 		$1K Sell
14
-23,583
-100% -$1.51M ﹤0.01% 299
2021
Q4 		$1.71M Buy
23,597
+6,744
+40% +$465K 1.47% 13
2021
Q3 		$1.18M Buy
+16,853
New +$1.18M 1.05% 16
2020
Q2 		– Sell
-44,705
Closed -$3.34M – 270
2020
Q1 		$3.34M Buy
+44,705
New +$3.09M 2.13% 12
2019
Q1 		– Sell
-7,198
Closed -$556K – 205
2018
Q4 		$556K Buy
+7,198
New +$503K 0.14% 117
2015
Q3 		– Sell
-5,295
Closed -$620K – 136
2015
Q2 		$620K Buy
+5,295
New +$579K 0.19% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

USA Financial Formulas's GILD Position: Q2 2026 in Review

USA Financial Formulas reduced its Gilead Sciences (GILD) stake by 96% in Q2 2026, selling an estimated $1.24M and leaving 398 shares worth $50.3K. The position accounts for 0.01% of the portfolio, ranked #278.

USA Financial Formulas first reported a position in GILD in Q2 2015 and has held it in 18 quarters since. The position peaked at $3.41M in Q1 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • USA Financial Formulas held 398 shares of Gilead Sciences worth $50.3K as of Q2 2026.
  • USA Financial Formulas sold 9,406 Gilead Sciences shares in Q2 2026, an estimated $1.24M.
  • Gilead Sciences made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #278 holding.
  • USA Financial Formulas first reported a position in Gilead Sciences in Q2 2015 and has held it in 18 quarters since.
  • USA Financial Formulas's Gilead Sciences position peaked at $3.41M in Q1 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.